silybin has been researched along with bromodeoxyuridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, C; Agarwal, R; Bhatia, N; Bosland, MC; Condon, MS; Tyagi, A | 1 |
| Agarwal, C; Agarwal, R; Dhanalakshmi, S; Mallikarjuna, G; Singh, RP | 1 |
| Agarwal, C; Agarwal, R; Kaur, M; Roy, S; Sclafani, RA; Tecklenburg, M | 1 |
3 other study(ies) available for silybin and bromodeoxyuridine
| Article | Year |
|---|---|
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Topics: Animals; Annexin A5; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Coloring Agents; DNA Damage; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Male; Propidium; Prostatic Neoplasms; Rats; Silybin; Silymarin; Trypan Blue; Tumor Cells, Cultured | 2002 |
Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
Topics: Administration, Oral; Administration, Topical; Animals; Apoptosis; Bromodeoxyuridine; Caspase 3; Caspases; Cell Cycle Proteins; Cell Division; Enzyme Activation; Female; MAP Kinase Signaling System; Mice; Mice, Hairless; Mitogen-Activated Protein Kinases; Neoplasms, Radiation-Induced; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Silybin; Silymarin; Skin; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays; Up-Regulation | 2004 |
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
Topics: Antioxidants; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase; Humans; Immunoprecipitation; Luciferases; Male; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Silybin; Silybum marianum; Silymarin | 2007 |